CN1138296A - 二甲硅油治疗便秘的应用 - Google Patents

二甲硅油治疗便秘的应用 Download PDF

Info

Publication number
CN1138296A
CN1138296A CN94194564A CN94194564A CN1138296A CN 1138296 A CN1138296 A CN 1138296A CN 94194564 A CN94194564 A CN 94194564A CN 94194564 A CN94194564 A CN 94194564A CN 1138296 A CN1138296 A CN 1138296A
Authority
CN
China
Prior art keywords
constipation
application
dimethyl polysiloxane
dimeticone
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN94194564A
Other languages
English (en)
Inventor
A·斯克米特
H-J·厄普迈耶
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN1138296A publication Critical patent/CN1138296A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/80Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Optical Recording Or Reproduction (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

本发明涉及应用二甲硅油作为治疗便秘的试剂。

Description

二甲硅油治疗便秘的应用
本发明涉及二甲硅油(dimeticone)治疗便秘的应用。
便秘是指干且硬的粪便从体内排出的时间延长。这是由于胃内容物通过肠道的时间延长引起的,或者是由于排便反射障碍引起的。通过肠道时间延长可能的原因是饮食因素,肠壁的改变或神经系统功能性或器质性疾病。药物也可能具有引起便秘的作用。在肛门系统疾病,在直肠扩张反射降低或施加腹压时腹肌无力的疾病中,可发现排便机理的缺陷。病人抱怨在排便期间的某些症状,如压力感,气胀感和疼痛感。
用轻泻药来治疗便秘,一方面可以软化干硬的粪便,另一方面可促进排便。
轻泻药发挥润滑剂,填充剂或膨胀剂的作用,具有盐水或渗透性,或产生抗吸收或促分泌作用。可以用很多方法将上述物质结合成商业制剂。
当用于长期治疗时,除了膨胀剂外,几乎所有的轻泻剂都会渐渐引起电解质代谢紊乱,并尤其引起钾的丢失,这反过来增加便秘。钠的丢失如此之高,以至引起继发性醛甾酮过多症(hyperaldes-teronism)。如此引起的钾丢失可导致肠能动性降低并且可能增加便秘。而且,当与强心苷合用治疗时,低血钾是最危险的。伴发的钙丢失可能促进骨质巯松症的发生,尤其是妇女。
给予膨胀剂可能引起胃内容物粘连到一起的危险,结果产生肠梗阻。
而且,很多轻泻剂可再吸收,结果可能产生大量全身性副作用。
因此,需要一种治疗便秘的有效的试剂,它不产生上述副作用并因此可用于患病的病人如儿童,中老年患者和妇女,尤其是孕妇。
根据本发明,发现二甲基聚硅氧烷(dimeticone)治疗便秘是有效的,并且不引起通常的副作用。
含二甲硅油的商业制剂可用于治疗适应症如气胀,饱腹(膨胀)感和腹中积气。而且,也曾经有人描述过用二甲硅油来治疗食管、胃和十二指肠的炎性和溃疡性疾病。
二甲基聚硅氧烷可以以片剂,胶囊剂,乳浊液,悬浮液和粉剂的形式口腔给予或与食物或食物补充剂混合的形式给予人或动物。可以将该组合物以安全并且有效的剂量给予人和动物以便得到需要的结果。典型地,本发明所使用的组合物包括有效量的二甲基聚硅氧烷和生物学上可接受的载体。这类载体可以是固体或液体,例如高度分散的二氧化硅,玉米淀粉,乳糖,蔗糖,葡萄糖,蔗糖,水,水和脂肪的乳浊液如硬脂酸甘油酯乳浊液和矫味剂。如果使用固体载体,那么剂量形式可以为片剂,胶囊剂或锭剂。液体剂量形式包括软明胶胶囊,糖浆剂或液体悬浮液。按照本发明,可以用常规方法使用含二甲硅油的组合物来治疗和预防便秘。本领域普通技术人员通过有效的方法和技术可选择剂量水平。特殊的剂量和治疗方案将依赖于某些因素,如健康状况,便秘的严重性和过程及其处理情况。
为了更彻底地理解本发明,阐述下列实施例。该实施例只用于说明的目的,并且不以任何方式限制本发明范围。
                   实施例
               治疗组合物的制备
将2kg含大约60g高度分散的二氧化硅的二甲基聚硅氧烷在约70℃的水浴中加热。然后加入充分研细的硬脂酸甘油酯(硬脂酸单甘油酯和二甘油酯的混合物)并将混合物保留在水浴中直到全部物质都融化。将混合物搅拌形成乳浊液,其中在大约70℃下,缓慢加入3升水。进一步搅拌并逐渐冷却后,形成稳定的含水乳浊液,在室温下,该乳浊液含有硬的象猪油一样的组合物。可以将该组合物精确地剂量化,与含有蔗糖、葡萄糖、乳糖和矫味剂的惰性制片物质混合并制成片剂。也可以用水稀释得到的物质来制备以滴剂形式给药的液体制剂。
              治疗组合物的应用
性别:              女
年龄:              2岁
诊断:              便秘
其它症状:          胫骨骨折(左侧)引起卧床不起
便秘持续时间:      3天
伴随症状:          非特异性症状性疼痛
治疗:              一茶匙二甲硅油悬浮液
结果:              2小时后完全排出粪便(大便)
由于要求病人固定不动,所以再过3天后情况与治疗前相同。再次给予大约40滴(一茶匙)二甲硅油悬浮液。当悬浮液开始发挥作用2小时后,使粪便完全排出。
尽管我们描述了本发明实施方案,显然我们的实施方案可以变更以提供利用本发明方法的其它实施方案。因此,应该理解,由所附权利要求来限定本发明范围,而不是由以实施例方式表示的特定实施方案来限定。

Claims (6)

1.二甲基聚硅氧烷制备治疗便秘的药用组合物的应用。
2.权利要求1的应用,其中二甲基聚硅氧烷与高度分散的二氧化硅联合应用。
3.权利要求1或2中任一项的应用,其中二甲基聚硅氧烷与生物学上可接受的乳化剂联合应用。
4.权利要求3的应用,其中乳化剂为硬脂酸甘油酯。
5.治疗儿童、中老年病人或孕妇便秘的根据权利要求1-4任一项的应用。
6.治疗便秘的含二甲基聚硅氧烷的可药用组合物。
CN94194564A 1993-12-02 1994-12-02 二甲硅油治疗便秘的应用 Pending CN1138296A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4341165.7 1993-12-02
DE4341165A DE4341165C1 (de) 1993-12-02 1993-12-02 Verwendung von Dimeticon zur Behandlung von Obstipation

Publications (1)

Publication Number Publication Date
CN1138296A true CN1138296A (zh) 1996-12-18

Family

ID=6504057

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94194564A Pending CN1138296A (zh) 1993-12-02 1994-12-02 二甲硅油治疗便秘的应用

Country Status (21)

Country Link
EP (1) EP0731705B1 (zh)
JP (1) JP4047376B2 (zh)
CN (1) CN1138296A (zh)
AT (1) ATE208202T1 (zh)
AU (1) AU1242095A (zh)
BG (1) BG100686A (zh)
CZ (1) CZ286371B6 (zh)
DE (2) DE4341165C1 (zh)
HU (1) HU216837B (zh)
IL (1) IL111804A (zh)
LT (1) LT4123B (zh)
LV (1) LV11593B (zh)
MD (1) MD1484F2 (zh)
NO (1) NO962221L (zh)
NZ (1) NZ277255A (zh)
PL (1) PL314799A1 (zh)
RU (1) RU2143907C1 (zh)
SI (1) SI9420073A (zh)
SK (1) SK70296A3 (zh)
WO (1) WO1995015170A1 (zh)
ZA (1) ZA949564B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY138097A (en) * 2000-03-22 2009-04-30 Du Pont Insecticidal anthranilamides
KR100442174B1 (ko) * 2001-09-25 2004-07-30 (주)다산메디켐 이산화규소, 폴리소르베이트류 및디메칠폴리실록산(디메치콘, 시메치콘)을 함유하는소화기장애에 사용되는 고형의 신규의약조성물
WO2005099821A1 (en) * 2004-04-13 2005-10-27 Boehringer Ingelheim International Gmbh Use of simethicone in constipated patients
DE102006001199A1 (de) * 2006-01-10 2007-07-12 Medicoforum Gmbh Fixe Kombination von Substanzen unter Beigabe von Entschäumern zum Einsatz als Darmspüllösung und/oder Laxans
DE102012024434A1 (de) 2012-12-14 2014-06-18 Regalismons S.A. Verstärkung der entschäumenden Wirkung von Polysiloxanen, zugehöriger Zusammensetzungen und Lösungen
IT202000001831A1 (it) * 2020-01-30 2021-07-30 Caprika Srl Composizione per applicazione rettale a base di sale di acido butirrico per il trattamento delle patologie proctologiche

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5549M (zh) * 1966-04-14 1967-11-20
FR2438431A1 (fr) * 1978-10-09 1980-05-09 Grimberg Georges Produits speciaux et compositions pharmaceutiques a base de son pour dispersions
DE3807712A1 (de) * 1987-07-25 1989-02-02 Nordend Apotheke Angela Hein Arzneimittel-trockenpraeparat zur bereitung einer laxativ wirkenden trinkloesung sowie ein verfahren zur herstellung dieses praeparates
EP0406248B1 (de) * 1989-01-19 1994-06-08 Alfred Schmidt Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes

Also Published As

Publication number Publication date
JPH09505824A (ja) 1997-06-10
SK70296A3 (en) 1997-06-04
NO962221D0 (no) 1996-05-30
ATE208202T1 (de) 2001-11-15
RU2143907C1 (ru) 2000-01-10
HU216837B (hu) 1999-09-28
ZA949564B (en) 1995-08-16
EP0731705B1 (en) 2001-11-07
PL314799A1 (en) 1996-09-30
CZ286371B6 (cs) 2000-03-15
DE4341165C1 (de) 1995-04-20
LT96094A (en) 1996-12-27
MD1484F2 (ro) 2000-06-30
NZ277255A (en) 1999-09-29
IL111804A (en) 2001-06-14
CZ157996A3 (en) 1997-01-15
HUT75529A (en) 1997-05-28
BG100686A (en) 1997-01-31
WO1995015170A1 (en) 1995-06-08
LV11593A (lv) 1996-12-20
AU1242095A (en) 1995-06-19
HU9601498D0 (en) 1996-07-29
DE69429013D1 (de) 2001-12-13
LT4123B (en) 1997-03-25
SI9420073A (en) 1997-02-28
LV11593B (en) 1997-04-20
NO962221L (no) 1996-06-14
IL111804A0 (en) 1995-01-24
JP4047376B2 (ja) 2008-02-13
EP0731705A1 (en) 1996-09-18

Similar Documents

Publication Publication Date Title
US5023245A (en) Improved niacin formulation
CA1333997C (en) Cholesterol-lowering combination compositions of guar gum and niacin
US5710183A (en) Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent
EP0428296B1 (en) Pharmaceutical compositions for treating gastrointestinal distress
WO2003053451A1 (de) Verwendung von ionischen und nichtionischen celluloseethern zur herstellung eines gelartigen mittels zur verhinderung der resorption von fetten aus dem magen-darm-trakt
US5418220A (en) Method for treating constipation using dimethicone
TW200930385A (en) Composition with active ingredient combination for the treatment of constipation
CN1138296A (zh) 二甲硅油治疗便秘的应用
DE69232126T3 (de) Aufnehmbare Zubereitungen enthaltend wasserlösliche, hochviskose Cellulosether
CA2177955C (en) Use of dimeticone for treating constipation
US6093423A (en) Reduced absorption of fatty acids
EP1844764B1 (de) Zusammensetzung zur Verwendung als Laxativum
DE2850791A1 (de) Pharmazeutisches mittel zur unterdrueckung des magen-rueckflusses
US20150374775A1 (en) Topical nutraceutical composition
Gangarosa et al. Drugs used in gastrointestinal disorders
PL178817B1 (pl) Galaretowata, przezroczysta emulsja na bazie ciekłego oleju parafinowego i laktulozy i sposób jej wytwarzania
Alphin et al. Irritative properties of two clinical potassium chloride formulations on duodenal mucosa of the cat and esophageal mucosa of the opossum
NZ529895A (en) Laxative preparation
US3152043A (en) Relieving constipation with non-ionic surface active agents
JPH0236568B2 (zh)
CN109091494A (zh) 羧酸基团修饰的水溶性淀粉盐在预防和治疗便秘中的应用
Smook, CH and Swanson Treatment of constipation: Part 2
AU2002312652A1 (en) Laxative preparation
JPH08295626A (ja) 関節アルカリ性鎮痛クリーム
DE202006009149U1 (de) Zusammensetzung zur Verwendung als Laxativum

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication